-+ 0.00%
-+ 0.00%
-+ 0.00%

3 UK Aerospace Stocks Retail Investors May Watch As Defence Spending Builds

Simply Wall St·07/16/2026 10:29:20
Listen to the news

The UK aerospace and defence sector is drawing fresh attention as Cambridge University prepares to open a high speed wind tunnel that blends physical testing with AI, while Rolls Royce discusses funding for a new aero engine. For investors, the theme is simple: follow where capital, technology and supply chain focus could concentrate next. This article looks at how that news might filter through to listed UK aerospace and defence stocks and what it could mean for risk and opportunity, before revealing 3 stocks from the screener that appear most directly exposed to these developments.

Cohort (AIM:CHRT)

Overview: Cohort is a defence technology group that supplies communications, sonar, surveillance, electronic warfare and training systems to armed forces and security customers across domains including land, sea, air, cyber and space, with operations spanning the UK, Europe, the Americas, Asia Pacific and Africa.

Operations: Cohort generates most of its revenue from its Sensors and Effectors segment at about £147.8 million and its Communications and Intelligence segment at about £132.0 million, with a small segment adjustment of £0.8 million.

Market Cap: £590.0 million

Cohort is positioned between specialist defence engineering and higher growth digital systems, supplying sonar, surveillance and secure communications that align with the push towards faster prototyping at facilities such as Cambridge University’s new wind tunnel and the wider shift to AI enabled defence platforms. Revenue of £306.39 million and net income of £23.9 million for FY2026, alongside a rising dividend, indicate a business active in critical programmes. The group, however, has to manage long project timelines, testing milestones and funding that currently relies on external borrowings. For investors, the key consideration is how these opportunities and constraints compare over the next few years, and whether Cohort’s current valuation reflects that balance.

Cohort’s mix of critical defence systems and reliance on external funding raises a clear question: is the current share price fully pricing in the project pipeline and balance sheet pressure revealed in the 1 key reward and 2 important warning signs (1 is major!)

AIM:CHRT Earnings & Revenue History as at Jul 2026
AIM:CHRT Earnings & Revenue History as at Jul 2026

Senior (LSE:SNR)

Overview: Senior plc supplies high tech components and systems that help manage fluids, heat and structural loads in aircraft, defence platforms, heavy vehicles and industrial equipment, serving major original equipment manufacturers across the US, UK and wider international markets.

Operations: Senior generates about £426.3 million of revenue from its Aerospace division and £313.4 million from Flexonics, with a small segment adjustment of £1.5 million. Sales are broadly split between the USA at £365.5 million and the rest of the world at £297.3 million, with £75.4 million from the UK.

Market Cap: £1.18b

Senior sits squarely in the sweet spot of the Cambridge wind tunnel story, supplying lightweight fluid conveyance and thermal management parts that are central to faster prototyping and more efficient aero engines. Its push into additive manufacturing and cooling systems for electrified trucks and hydrogen projects gives investors exposure to cleaner transport and aerospace programmes. The Flexonics arm links into wider energy and industrial spending tied to efficiency and emissions rules. Against that, earnings have been uneven, with a recent one off loss of £8.7 million, modest 3.7% net margins and reliance on external borrowing. The appeal rests on whether future programme ramp ups and R&D payoffs justify those financial risks and the current P/E premium.

Senior’s uneven earnings and reliance on external borrowing could be masking where the real story sits. Before assuming future programme wins will do the heavy lifting, review the 2 key rewards and 1 important warning sign.

LSE:SNR Revenue & Expenses Breakdown as at Jul 2026
LSE:SNR Revenue & Expenses Breakdown as at Jul 2026

Avon Technologies (LSE:AVON)

Overview: Avon Technologies provides respiratory and head protection equipment for military personnel and first responders, selling products such as respirators, escape hoods, thermal imaging cameras, rebreathers and ballistic helmets under the Avon Protection and Team Wendy brands across Europe and the United States.

Operations: Avon Technologies generates about $186.2 million of revenue from its Avon Protection segment and $139.8 million from Team Wendy, with most sales reported in the United States at $247.8 million.

Market Cap: £488.9 million

Avon Technologies sits close to the heart of the UK Aerospace & Defence Innovation theme, supplying life support and protection systems that are essential whenever new platforms move from the wind tunnel to the field. A record order book of around $200 million, fresh NATO and US Department of Defense contracts and product launches like the next generation CS PAPR and new rebreathers indicate that its equipment is being specified into long term programmes. At the same time, the STAR transformation work aims to lift productivity and margins. Set against that, a relatively high P/E multiple, reliance on external borrowing and timing risks around plant moves and contract phasing mean investors still need to judge whether today’s valuation fully reflects the mix of progress and execution risk.

Avon Technologies’ record order book and new contracts could be only half the story. Before assuming the STAR programme and new kit are fully reflected in expectations, scan the analyst forecasts for Avon Technologies and see what might be missing.

LSE:AVON Earnings & Revenue Growth as at Jul 2026
LSE:AVON Earnings & Revenue Growth as at Jul 2026

The three UK aerospace and defence stocks in this article are only a starting point, with the full UK Aerospace & Defence Innovation screen surfacing 19 more companies that carry equally compelling stories around scale, balance sheets and exposure to new technology programmes through the UK Aerospace & Defence Innovation screener. Use Simply Wall St to identify and analyse the catalysts that matter to you, from order book trends and R&D intensity to balance sheet strength and earnings quality, so you can focus on the highest conviction ideas in this theme.

Take Control of Your Investment Journey

If Cohort or any of these companies sound like a great opportunity, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value the ideal entry point. Once you've made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates. Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives. By uncovering hidden catalysts and risks early, you'll accelerate your decision-making and stay one step ahead of the market.

Seeking Fresh Alternatives Before They Fly?

New ideas move fast, and the best entry points can vanish once momentum builds. Scan fresh stock lists before they stop looking under the radar for now, and consider acting before conditions change.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.